Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis-Reference-Cited by-同舟云学术

Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis

Published:2021-07 Issue: Volume:52 Page:103028
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Allen-Philbey K.^ORCID,Stennett A.,Begum T.,Johnson AC.,Dobson R.,Giovannoni G.,Gnanapavan S.,Marta M.,Smets I.,Turner B.P.,Baker D.,Mathews J.,Schmierer K.^ORCID

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference10 articles.

1. Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis;Salter;JAMA Neurol,2021

2. COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases;Baker;Clinical & Experimental Immunology,2020

3. What policy makers need to know about COVID-19 protective immunity;Altmann;Lancet,2020

4. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination;Greinacher;N. Engl. J. Med.,2021

5. Protecting people with multiple sclerosis through vaccination;Reyes;Pract. Neurol.,2020

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global burden of vaccine‐associated multiple sclerosis, 1967–2022: A comprehensive analysis of the international pharmacovigilance database;Journal of Medical Virology;2024-04

2. Immunogenicity and safety of vaccines in multiple sclerosis: A systematic review and meta-analysis;Journal of the Neurological Sciences;2024-01

3. Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021);Current Journal of Neurology;2023-05-03

4. Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis;Multiple Sclerosis Journal;2023-02-01

5. COVID-19 in children and adolescents with neuroimmunological disorders;Clinics;2023-01